Remed Co

Remed Co Days Payable Outstanding

The Days Payable Outstanding (DPO) of Remed Co (302550.KQ) as of Nov 19, 2026 is 23.60. In the previous year, Days Payable Outstanding (DPO) was 23.11 — a change of 2.12% (higher).

Days Payable Outstanding

23.60

YoY

2.12%

Last updated:

Days Payable Outstanding (DPO) of Remed Co is 2025 23.60 . Days Payable Outstanding (DPO) of Remed Co was 2024 23.11 . It decreases by 2.12% higher compared to the previous year.

The Remed Co Days Payable Outstanding history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Days Payable Outstanding
Date
Days Payable Outstanding
Jan 1, 2019
27.95 KRW
Jan 1, 2020
11.55 KRW
Jan 1, 2021
29.53 KRW
Jan 1, 2022
9.83 KRW
Jan 1, 2023
20.26 KRW
Jan 1, 2024
23.11 KRW
Jan 1, 2025
23.60 KRW
The Remed Co Days Payable Outstanding history
YEARDays Payable OutstandingYoY
23.60+2.12%
23.11+14.06%
20.26+106.08%
9.83-66.71%
29.53+155.76%
11.55-58.70%
27.95—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Remed Co Stock analysis

What does Remed Co do? REMED Co., Ltd. generates revenue through the manufacturing and sale of medical equipment, including transcranial magnetic stimulation (TMS) therapy machines, pain therapy machines, and biosignal and monitoring machines. Pain therapy machines encompass electromagnetic stimulation machines, extracorporeal shockwave therapy machines, and high intensity laser therapy machines. Biosignal and monitoring machines include patient monitors, fetal monitors, and electrocardiogram (ECG/EKG) machines. The company distributes these products domestically and internationally, targeting healthcare providers and medical facilities that require specialized therapeutic and monitoring solutions. The firm's product portfolio focuses on advanced medical devices for neurological and pain management, as well as patient monitoring. Transcranial magnetic stimulation (TMS) therapy machines are used for neurological treatments, while pain therapy machines address chronic pain conditions. Biosignal and monitoring machines support critical patient care, with electrocardiogram (ECG/EKG) machines being a key component. These products are sold to hospitals, clinics, and medical centers across domestic and overseas markets. REMED Co., Ltd. serves healthcare institutions that require specialized equipment for diagnosis, treatment, and monitoring. The domestic market includes hospitals and clinics in Daejeon, while overseas markets extend to international healthcare providers. The company’s revenue streams are derived from direct sales of its medical equipment, with no mention of additional services or licensing agreements in the business description. Remed Co is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Remed Co stock

Days Payable Outstanding (DPO) of Remed Co is 23.60 in 2025.

Days Payable Outstanding (DPO) of Remed Co changed from 23.11 to 23.60, representing a 2.12% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Days Payable Outstanding (DPO) Remed Co since 2006 – with annual values, charts, and detailed analysis.

DPO measures the average number of days a company takes to pay its suppliers. Higher DPO can improve cash flow but may strain supplier relationships.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Days Payable Outstanding (DPO)'s Remed Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Days Payable Outstanding (DPO)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Days Payable Outstanding (DPO).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Remed Co

All Key Metrics — Remed Co